Literature DB >> 5032679

Plasma turnover of methyldopa in advanced renal failure.

E Myhre, E K Brodwall, O Stenbaek, T Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5032679

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  7 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Pharmacokinetics of methyldopa in healthy man.

Authors:  O Stenbaek; E Myhre; H E Rugstad; E Arnold; T Hansen
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

3.  Comparative bioavailability of alpha-methyldopa normal and film tablet formulations after single oral administration in healthy volunteers.

Authors:  K Róna; K Ary; G Renczes; B Gachályi; G Y Grézal; S Drabant; I Klebovich
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

Review 4.  Clinical pharmacokinetics of methyldopa.

Authors:  E Myhre; H E Rugstad; T Hansen
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

5.  The pharmacokinetics of alpha-methyldopa in dogs.

Authors:  G M Kochak; W D Mason
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

6.  Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure.

Authors:  Y H Lee; M H Lee; C K Shim
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

7.  A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy.

Authors:  H M Jones; A J Cummings; K D Setchell; A M Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.